School of Medicine
Showing 9,601-9,650 of 13,053 Results
-
Daniela Rodriguez Martinez
Assistant Manager, Communications, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordAssistant Manager, Communications @Stanford Byers Center for Biodesign
-
Kacper Rogala
Assistant Professor of Structural Biology and of Chemical and Systems Biology
Current Research and Scholarly InterestsOur team is fascinated by how cells make growth decisions — to grow or not to grow. In order to grow, cells require nutrients, and we are unraveling how cells use specialized protein sensors and transporters to sense and traffic nutrients in between various compartments. We use approaches from structural biology, chemical biology, biophysics, biochemistry, and cell biology — to reveal the mechanisms of basic biological processes, and we develop chemical probes that modulate them.
-
Albert "A.J." Rogers, MD, MBA, FAHA
Instructor, Medicine - Cardiovascular Medicine
BioDr. Rogers is a board-certified, fellowship-trained cardiologist with the Cardiac Arrhythmia Service at Stanford Health Care. He is also an instructor of medicine in the Division of Cardiovascular Medicine, Department of Medicine at Stanford University School of Medicine.
As a clinical cardiac electrophysiologist, Dr. Rogers’ training includes evaluating issues involving electrical activity in the heart and how these can lead to an abnormal heart rhythm (arrhythmia). His expertise includes mapping regions in the heart associated with arrhythmias and then applying a minimally invasive therapy (ablation) that targets the responsible areas causing the problem. He also performs procedures to implant cardiac devices, such as pacemakers and defibrillators, designed to synchronize heart contractions and reset irregular heartbeats.
Dr. Rogers specializes in the diagnosis and treatment of atrial fibrillation, ventricular tachycardia, and other arrhythmias. In collaboration with Stanford Medicine cardiovascular surgeons, he performs hybrid surgical-catheter ablation procedures as a more permanent treatment for persistent forms of atrial fibrillation and for inappropriate sinus tachycardia. During this procedure, ablation therapy is applied to areas both inside and outside of the heart responsible for the arrhythmia.
As a physician-researcher, Dr. Rogers’ translational research applies biomedical engineering and machine learning approaches to explore the mechanisms underlying cardiac arrhythmia. These efforts include research funded by the National Institutes of Health and the American Heart Association to investigate novel methods for diagnosing and treating heart rhythm disorders. Dr. Rogers has over 10 years of experience with medical technology innovation and development.
Dr. Rogers serves as associate editor of the Journal of Invasive Cardiovascular Electrophysiology. He is also a peer reviewer for multiple prestigious journals, including Heart Rhythm, The Lancet: Digital Health, the Journal of the American College of Cardiology: Clinical Electrophysiology, and Frontiers in Physiology. He has been an invited guest speaker at national and international meetings, including those for the American Heart Association and the European Cardiac Arrythmia Society. -
Angela Rogers
Professor of Medicine (Pulmonary and Critical Care)
Current Research and Scholarly InterestsWe use genetics and genomics methodologies to identify novel ARDS pathobiology; we hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease. We are building a plasma biobank of critically ill patients at Stanford, with a particular focus on metabolic changes in critical illness.
-
India Bahia Rogers-Shepp
Affiliate, Department Funds
Resident in Obstetrics & GynecologyBioIndia Rogers-Shepp is originally from New York City. She graduated from Princeton University with her BA in molecular biology in 2018 and a certificate in Dance. The following year she graduate from Brown University with a Master's in Science in Medical Sciences in 2019. She entered Stanford Medical School in 2020. During her time here, she has pursued her passions for women's health, queer health, equity for the unhoused, and environmental justice. India's future career goal is to become an OB/GYN who centers the reproductive health of the unhoused and those made most vulnerable by climate change through her clinical practice and research.
-
Alissa Megan Rogol
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioAcademic interests include child and adolescent psychiatry, forensic psychiatry, medical ethics and palliative care.
-
Eugene Y. Roh, MD
Clinical Professor, Orthopaedic Surgery
Current Research and Scholarly InterestsTherapeutic Efficacy of biologic treatments(Platelet Rich Plasma, adipose, mfat, bone marrow, stem cell) in OA and tendonitis
Application of musculoskeletal ultrasound for sports medicine and other musculoskeletal disease.
AI-based musculoskeletal diagnosis and treatment in sports, OA and tendinitis -
Nidhi Rohatgi, MD MS
Clinical Professor, Medicine
Clinical Professor (By courtesy), Neurosurgery
Clinical Professor (By courtesy), Anesthesiology, Perioperative and Pain MedicineBioNidhi Rohatgi, MD, MS, SFHM, is a Clinical Professor of Medicine and (by courtesy) Neurosurgery, Anesthesiology, Perioperative, and Pain Medicine at Stanford University School of Medicine. She served as Chief of Surgical Co-management for Neurosurgery, ENT, and Orthopedic Surgery at Stanford. Dr. Rohatgi is Affiliate Faculty at Stanford's Center for Artificial Intelligence in Medicine and Imaging (AIMI) and Center for Digital Health. She served as Co-Director of Clinical Research in Hospital Medicine and Physician Lead of Stanford Health Care's Readmissions Committee.
Dr. Rohatgi has authored peer-reviewed articles in high-impact journals (NEJM, Lancet, JAMA, Nature, Annals of Surgery), led workshops and webinars, and written book chapters in Perioperative Medicine. She is a global advisor on surgical co-management models and chaired the Society of Hospital Medicine's Global Technical Advisory Committee on co-management. Dr. Rohatgi serves as the Editor-in-Chief for JMIR Perioperative Medicine journal and is on the Editorial Board for Brown University's Journal of Hospital Medicine. She has been an invited speaker at several regional, national, and international meetings.
Dr. Rohatgi has served as Medical Director for Clinical Advice Services in Patient Experience at Stanford for over 10 years, overseeing after-hours clinical support and triage for 30+ services and 180+ clinics, and handling 90,000+ calls annually. This award-winning service has a strong track record in patient safety, reducing unnecessary ED and clinic visits, and reducing pages to on-call teams by over 90%.
She has served on multiple national committees: Society of Hospital Medicine's Research Committee, Hospital Quality and Patient Safety Committee, Perioperative Medicine Executive Council, Practice Management Committee, Perioperative and Consultative Medicine Educational Portal Planning Committee, and Leadership Committee for the Hospital Medicine National Writing Challenge. Dr. Rohatgi has served as a principal investigator and co-investigator for NIH and industry-sponsored trials. Recognized as a Top Hospitalist by the American College of Physicians, she has received numerous national and international awards for clinical care, quality improvement, teaching, and research.
Dr. Rohatgi has written on LLMs for clinical text summarization and pharmacogenomics, multimodal in-context learning (presented at NeurIPS), promises and limitations of AI, and digital twins. She will be the keynote speaker on AI in Healthcare at 2026 IEEE International Conference on Intelligent Computing and Sustainable Innovation in Technology. In her upcoming book, Dr. Rohatgi shares a blueprint for AI in medicine: where AI can help and how, global health AI trends, and tackling costs. Her unique lens spans clinical experience in rural India to Silicon Valley, managing patients in medical and surgical specialties, research on millions of patient records, investigator for clinical trials, patient experience, clinical triage, and health system operations. Dr. Rohatgi is passionate about innovative, value-based, sustainable solutions, and exploring new frontiers in healthcare. -
Rajat Rohatgi
Professor of Biochemistry and of Medicine (Oncology)
Current Research and Scholarly Intereststhe overall goal of my laboratory is to uncover new regulatory mechanisms in signaling systems, to understand how these mechanisms are damaged in disease states, and to devise new strategies to repair their function.
-
Benjamin Rolles
Postdoctoral Scholar, Hematology
BioMD/Research Fellow
@MullallyLab @StanfordMed @VAPaloAlto @BrighamHeme @BrighamResearch @HarvardMed
Studied
@UniklinikAachen @RWTH
Interested in MPN & Myeloid Malignancies -
Dana Nirel Romalis
Clinical Assistant Professor, Medicine - Vaden Health Center
BioDana Romalis has been a board certified Family Medicine physician since 2004. She enjoys taking care of people throughout all phases of life. Special interests include teaching, collaborative care, preventative medicine, behavioral change, and reproductive and adolescent health. Since 2017, she has been a clinician educator with Stanford's department of primary care and population health. Her current clinical practice is at the Vaden student health center on campus.
She was born and raised in Vancouver, Canada, where she also attended medical school at the University of British Columbia. As an undergraduate at Brandeis University, she double majored in Neuroscience and Psychology, and was captain of the women’s varsity diving team. She did her residency at Montefiore Medical Center’s Residency Program of Social Medicine in the Bronx, NY.
Prior to joining Stanford’s primary care division in 2017, she was a primary care physician on Santa Clara Valley Medical Center's interdisciplinary Homeless Healthcare Program for 10 years. She is committed to comprehensive and compassionate care for all.
In her spare time, she enjoys spending time with her husband and 2 adult children, reading, hiking, and volunteering in her community. -
Maria Grazia Roncarolo
George D. Smith Professor of Stem Cell and Regenerative Medicine, Emerita
Current Research and Scholarly InterestsResearch Interests
Immunetolerance: Mechanisms underlying T-cell tolerance, induction of T-cell anergy and regulatory T cells; Immunomodulation: mAbs, proteins and low molecular weight compounds which can modulate T-cell activation; Primary immunodeficiencies: Characterization of molecular and immunological defects; Gene therapy: Gene transduction of hematopoietic cells for gene therapy in primary immunodeficiencies and metabolic diseases; Hematopoiesis: Mechanisms underlying growth and differentiation of hematopoietic stem cells; Transplantation: Immune reconstitution and T-cell tolerance after allogenic stem cell transplantation; Cytokines/Cytokine receptors: Role in regulation of immune and inflammatory responses
Clinical Interests
Primary Immunodeficiencies
Monogenic Autoimmune Disorders
Allogenic Bone Marrow Transplantation
Gene Therapy Clinical Trials
Cell Therapy Clinical Trials
Clinical Trials in Autoimmune Diseases and Organ Transplantation
Clinical Trials in Hemoglobinopathies -
Morteza Roodgar DVM, PhD
Veterinarian Research Scientist, Genetics
BioDr. Morteza Roodgar is a veterinarian scientist with a research focus on Primate induced Pluripotent Stem Cells (iPSCs) and long-read genomics tools.
Dr. Roodgar's research focus is on primate stem cell biology, immunology, and comparative genomics of nonhuman primate models for human diseases. The long-term goal of Dr. Roodgar's research is to Replace, Reduce and Refine (aka 3 R’s) the use of animals in biomedical research leveraging primate induced pluripotent stem cells (iPSCs) and long-read genomic tools to speed up preclinical testing.
Previous research includes immunology and genomic susceptibility to infectious diseases (e.g., tuberculosis, TB) in nonhuman primate models, Preventive Veterinary Medicine and emerging zoonotic diseases (e.g., COVID-19 and Monkeypox). -
Michal Bental Roof
Academic Prog Prof 3, Pediatrics - Cardiology
Current Role at StanfordI joined the Cardiopulmonary Research Program of Drs. Rabinovitch and Bland at Stanford University in 2002, as the Academic and Research Program Officer, and since 2020 assumed my role at the Basic Science and Engineering (BASE) Initiative at the Betty Irene Moore Children's Heart Center, directed by Dr. Rabinovitch. I organize the educational activities of the lab, and assist the faculty and fellows with the preparation of grant proposals, IRB, APLAC and Biosafety protocols, manuscripts, and presentations. I served as the Site Coordinator for the Stanford Transplant Procurement Center of the Pulmonary Hypertension Breakthrough Initiative (PHBI), headed by Dr. Rabinovitch,that now evolved into the Stanford Transplant Tissue Bank. In this capacity, I oversee patient recruitment, data collection and reporting, and ensure compliance with university and federal guidelines. I coordinated and prepared the application for an Investigational New Drug (IND) and the pre-IND meeting that preceded that, for Elafin as a therapy for pulmonary arterial hypertension (PAH) to the FDA in August 2017, and with the Study PIs coordinated the Phase 1 clinical trial “Safety and Tolerability of Escalating Doses of Subcutaneous Elafin (Tiprelestat) Injection in Healthy Normal Subjects” that followed.
From 2005-2015, I served as the Administrative Coordinator of the Cardiovascular and Pulmonary Science Scholarly Concentration for medical students at Stanford University School of Medicine. This includes facilitating communication of the four co-Directors with the School of Medicine Administration, the medical students, and the faculty mentors. An important component of this role is the coordination of the MED223 course, a medical school course where faculty and fellows present new developments in cardiovascular science in the form of a journal club. From 2013-2018, I was the coordinator for the NIH-NHLBI T32 “Mechanisms and Innovation in Vascular Disease” (PI: RL Dalman), and from 2013 to date for NIH-NHLBI K12 HL120001 “Stanford Career Development Program in ‘Omics’ of Lung Disease”. (PIs: M Rabinovitch, MR Nicolls and MP Snyder). This included recruitment of candidates, oversight of training activities, ensuring compliance with NIH and Stanford policies, and acting as a liaison between the trainees and the Directors to facilitate effective communication.
Prior to joining Stanford, I was Associate Director (Scientific Development Administrator) at the Institute for Medicine and Engineering, directed by Dr. Peter Davies at the University of Pennsylvania. In this role, I was the liaison with federal funding agencies and organized multi-investigator program projects and training grants.
